T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
Open Access
- 1 April 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 179 (4) , 1297-1305
- https://doi.org/10.1084/jem.179.4.1297
Abstract
Epstein-Barr virus (EBV) is a B lymphotropic herpesvirus of humans that elicits strong HLA class I-restricted cytotoxic T lymphocyte (CTL) responses. An influence of such responses on virus evolution was first suggested by our finding that EBV isolates from the highly HLA A11-positive Papua New Guinea (PNG) population carried a lys-thr mutation at residue 424 of the nuclear antigen EBV-encoded nuclear antigen (EBNA4) that destroyed the immunodominant target epitope for A11-restricted CTL recognition. Here we turn to a much larger population, Southern Chinese, where the A11 allele is again present in over 50% of the individuals. Each of 23 EBV isolates analyzed from this population were also mutated in the EBNA4 416-424 epitope, the mutations selectively involving one of the two anchor residues in positions 2 (417 val-leu) or 9 (424 lys-asp, -arg or -thr) that are critical for A11-peptide interaction. The majority of the Chinese isolates and all 10 PNG isolates also carried mutations affecting positions 1 and 2 of the next most immunodominant A11-restricted epitope, EBNA4 residues 399-408. These changes clearly affected antigenicity since A11-positive lymphoblastoid cell lines (LCLs) carrying these mutant EBV strains were not recognized by A11-restricted CTLs raised against the prototype B95.8 virus. Furthermore, Chinese donors naturally infected with these mutant viruses did not mount detectable A11-restricted CTL responses on in vitro stimulation with autologous LCL cells carrying either the B95.8 or their endogenous EBV strain. In two different highly A11-positive populations, therefore, immune pressure appears to have selected for resident EBV strains lacking immunodominant A11-restricted CTL epitopes.Keywords
This publication has 21 references indexed in Scilit:
- Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide.The Journal of Experimental Medicine, 1993
- An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.Proceedings of the National Academy of Sciences, 1993
- Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.Proceedings of the National Academy of Sciences, 1992
- Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.The Journal of Experimental Medicine, 1992
- HLA-DR-antigen-associated restriction of EBV-specific cytotoxic T-cell coloniesInternational Journal of Cancer, 1984
- Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.The Journal of Immunology, 1981
- Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virusNature, 1978
- An HLA Map of EuropeHuman Heredity, 1978
- Standards for Total Serum Protein Assays— A Collaborative StudyClinical Chemistry, 1975
- Release of Infectious Epstein-Barr Virus by Transformed Marmoset LeukocytesProceedings of the National Academy of Sciences, 1973